Baseline parameters according to the group and clinical categories of HbA1c
| Parameters | HbA1c categories | p Value (HbA1c <5.7% vs ≥5.7%) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| HbA1c<5.7% | HbA1c≥5.7% | ||||||||
| All (n=117) | ILG (n=61) | UCG (n=56) | p Value | All (n=177) | ILG (n=84) | UCG (n=93) | p Value | ||
| Age (years) | 50.1±6.8 | 50.0±6.9 | 50.1±6.8 | 0.94 | 51.9±5.8 | 51.9±6.2 | 52.0±5.6 | 0.89 | 0.02 |
| Male (%) | 59.0 | 59.0 | 58.9 | 0.99 | 44.6 | 44.0 | 45.2 | 0.88 | 0.02 |
| Body weight (kg) | 64.6±12.4 | 65.6±12.5 | 63.5±1.6 | 0.36 | 64.4±12.2 | 64.3±12.8 | 64.4±11.6 | 0.95 | 0.89 |
| BMI (kg/m2) | 24.3±3.7 | 24.5±3.5 | 24.1±3.8 | 0.63 | 24.9±3.4 | 24.8±3.4 | 24.9±3.0 | 0.96 | 0.19 |
| Fasting plasma glucose (mmol/L) | 5.8±0.5 | 5.8±0.5 | 5.8±0.6 | 0.66 | 6.1±0.5 | 6.0±0.5 | 6.1±0.5 | 0.06 | <0.01 |
| 2 h plasma glucose (mmol/L) | 8.9±0.8 | 9.0±0.7 | 8.9±0.9 | 0.49 | 9.1±0.9 | 9.2±0.9 | 9.1±0.9 | 0.24 | 0.03 |
| HOMA-β | 68.7±37.3 | 69.7±35.7 | 67.7±39.2 | 0.77 | 56.9±26.3 | 57.8±27.3 | 56.1±25.5 | 0.67 | <0.01 |
| HbA1c (%) | 5.4±0.2 | 5.4±0.2 | 5.4±0.2 | 0.14 | 6.0±0.2 | 6.0±0.2 | 6.0±0.3 | 0.98 | <0.01 |
Data were means±SD.
BMI, body mass index; HbA1c, glycated hemoglobin; HOMA-β, homeostatic model assessment β-cell function; ILG, intensive lifestyle intervention group; UCG, usual care group.